Mostrar el registro sencillo del ítem

dc.contributor.authorMartinón Torres, Federico 
dc.contributor.authorAramburo Caragol, Ángela 
dc.contributor.authorMartinon Torres, Nazareth 
dc.contributor.authorCebey López, Miriam
dc.contributor.authorSeoane Pillado, María Teresa 
dc.contributor.authorRedondo Collazo, Lorenzo 
dc.contributor.authorMartinón Sánchez, José María 
dc.date.accessioned2017-06-07T07:02:53Z
dc.date.available2017-06-07T07:02:53Z
dc.date.issued2013
dc.identifier.issn2164-5515
dc.identifier.urihttp://hdl.handle.net/20.500.11940/2030
dc.description.abstractIn 2010, and due to a quality problem identified in the vaccine manufacture, the rotavirus (RV) vaccination was withheld in Spain during 5 months. Our study aimed to evaluate the impact that this sudden cease had on rotavirus acute gastroenteritis (RAGE) hospitalizations. An increase in RAGE hospitalization was observed in parallel to the drop in vaccine coverage. Here, we report the first reverse evidence of rotavirus vaccine impact.
dc.language.isoeng
dc.subject.meshChild, Preschool
dc.subject.meshFemale
dc.subject.meshGastroenteritis
dc.subject.meshHospitalization
dc.subject.meshHumans
dc.subject.meshInfant
dc.subject.meshInfant, Newborn
dc.subject.meshMale
dc.subject.meshRetrospective Studies
dc.subject.meshRotavirus Infections
dc.subject.meshRotavirus Vaccines
dc.subject.meshSafety-Based Drug Withdrawals
dc.subject.meshSpain/epidemiology
dc.subject.meshVaccination
dc.subject.meshVaccine effectiveness
dc.subject.meshgastroenteritis
dc.subject.meshhospitalization
dc.subject.meshrotavirus infections
dc.subject.meshrotavirus vaccines
dc.titleA reverse evidence of rotavirus vaccines impact
dc.typeArtigoes
dc.authorsophosMartinón-Torres, F.
dc.authorsophosAramburo, A.
dc.authorsophosMartinón-Torres, N.
dc.authorsophosCebey, M.
dc.authorsophosSeoane-Pillado, M. T.
dc.authorsophosRedondo-Collazo, L.
dc.authorsophosMartinón-Sánchez, J. M.
dc.identifier.doi10.4161/hv.24182
dc.identifier.isi330380700022
dc.identifier.pmid23836258
dc.identifier.sophos12529
dc.issue.number6
dc.journal.titleHuman Vaccines & Immunotherapeutics 
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Pediatría
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago::IDIS.- Instituto de investigaciones sanitarias de Santiago
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Epidemioloxía
dc.page.initial1289
dc.page.final91
dc.relation.publisherversionhttps://www.tandfonline.com/doi/pdf/10.4161/hv.24182?needAccess=true
dc.rights.accessRightsopenAccess
dc.typesophosArtículo Original
dc.volume.number9


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem